Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP417051.RA40y85Oj9A7CC8LBO76ypqZ19DJqdAimyZ7grCSRecdU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP417051.RA40y85Oj9A7CC8LBO76ypqZ19DJqdAimyZ7grCSRecdU130_assertion type Assertion NP417051.RA40y85Oj9A7CC8LBO76ypqZ19DJqdAimyZ7grCSRecdU130_head.
- NP417051.RA40y85Oj9A7CC8LBO76ypqZ19DJqdAimyZ7grCSRecdU130_assertion description "[Increased RGS17 expression in some prostate and lung cancers has been demonstrated to support cancer progression, while reduced expression of RGS17 can lead to development of chemotherapeutic resistance in ovarian cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP417051.RA40y85Oj9A7CC8LBO76ypqZ19DJqdAimyZ7grCSRecdU130_provenance.
- NP417051.RA40y85Oj9A7CC8LBO76ypqZ19DJqdAimyZ7grCSRecdU130_assertion evidence source_evidence_literature NP417051.RA40y85Oj9A7CC8LBO76ypqZ19DJqdAimyZ7grCSRecdU130_provenance.
- NP417051.RA40y85Oj9A7CC8LBO76ypqZ19DJqdAimyZ7grCSRecdU130_assertion SIO_000772 23734683 NP417051.RA40y85Oj9A7CC8LBO76ypqZ19DJqdAimyZ7grCSRecdU130_provenance.
- NP417051.RA40y85Oj9A7CC8LBO76ypqZ19DJqdAimyZ7grCSRecdU130_assertion wasDerivedFrom befree-20140225 NP417051.RA40y85Oj9A7CC8LBO76ypqZ19DJqdAimyZ7grCSRecdU130_provenance.
- NP417051.RA40y85Oj9A7CC8LBO76ypqZ19DJqdAimyZ7grCSRecdU130_assertion wasGeneratedBy ECO_0000203 NP417051.RA40y85Oj9A7CC8LBO76ypqZ19DJqdAimyZ7grCSRecdU130_provenance.